Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jin Seo Lee, Mi Suk Lee, Yoonseon Park, Jacob Lee, Eun-Jeong Joo & Joong Sik Eom. (2020) Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients. Infection and Drug Resistance 13, pages 1479-1484.
Read now
Read now
Matteo Bassetti, Nadia Castaldo & Alessia Carnelutti. (2019) Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives. Expert Opinion on Pharmacotherapy 20:14, pages 1711-1718.
Read now
Read now
Mazhar Hussain, Henry D Galvin, Tatt Y Haw, Ashley N Nutsford & Matloob Husain. (2017) Drug resistance in influenza A virus: the epidemiology and management. Infection and Drug Resistance 10, pages 121-134.
Read now
Read now
Ashley Wester & Avinash K Shetty. (2016) Peramivir injection in the treatment of acute influenza: a review of the literature. Infection and Drug Resistance 9, pages 201-214.
Read now
Read now
Articles from other publishers (48)
Andrey Bogoyavlenskiy, Irina Zaitseva, Pavel Alexyuk, Madina Alexyuk, Elmira Omirtaeva, Adolat Manakbayeva, Yergali Moldakhanov, Elmira Anarkulova, Anar Imangazy, Vladimir Berezin, Dmitry Korulkin, Aso Hameed Hasan, Mahmoud Noamaan & Joazaizulfazli Jamalis. (2023) Naturally Occurring Isorhamnetin Glycosides as Potential Agents Against Influenza Viruses: Antiviral and Molecular Docking Studies. ACS Omega.
Crossref
Crossref
Dagmara Bialy, Samuel Richardson, Klaudia Chrzastek, Sushant Bhat, Noemi Polo, Graham Freimanis, Munir Iqbal & Holly Shelton. (2023) Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo. Virology, pages 109954.
Crossref
Crossref
Sihan Wang, Tian-hao Zhang, Menglong Hu, Kejun Tang, Li Sheng, Mengying Hong, Dongdong Chen, Liubo Chen, Yuan Shi, Jun Feng, Jing Qian, Lifeng Sun, Kefeng Ding, Ren Sun & Yushen Du. (2023)
Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations
in vivo
. mSystems 8:5.
Crossref
Crossref
Vanessa Escuret & Olivier Terrier. (2023) Co-infection of the respiratory epithelium, scene of complex functional interactions between viral, bacterial, and human neuraminidases. Frontiers in Microbiology 14.
Crossref
Crossref
Jinna Wang, Hongdou Chen, Lie Zhuo, Ying Guo, Xu Wang, Lina Chen & Fangfang Zheng. (2023) Effectiveness of intravenous peramivir for the treatment of influenza A/H3N2 and influenza B/Victoria in hospitalized children. Journal of Infection and Chemotherapy.
Crossref
Crossref
Guo-Qiang Zhang, Hao Chang, Zhiyuan Gao, Yang-ping Deng, Sheng Zeng, Luqing Shang, Dan Ding & Qian Liu. (2023) Neuraminidase-Activatable NIR Fluorescent Probe for Influenza Virus Ratiometric Imaging in Living Cells and Colorimetric Detection on Cotton Swabs. ACS Materials Letters 5:3, pages 722-729.
Crossref
Crossref
Jeremy C. Jones, Hui-Ling Yen, Peter Adams, Kimberly Armstrong & Elena A. Govorkova. (2023) Influenza antivirals and their role in pandemic preparedness. Antiviral Research 210, pages 105499.
Crossref
Crossref
Pobitra Borah, Sangeeta Hazarika, Mohamed A. Morsy, Manoj Goyal, Ashna Chettri, Katharigatta N. Venugopala, Viresh Mohanlall, Pratap Chandra Acharya, Pran Kishore Deb & Raghu Prasad Mailavaram. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
319
359
.
Walid F. Elkhatib, Shereen S. Abdelkareem, Wafaa S. Khalaf, Mona I. Shahin, Dounia Elfadil, Alaa Alhazmi, Ahmed I. El-Batal & Gharieb S. El-Sayyad. (2022) Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting. Virology Journal 19:1.
Crossref
Crossref
Edita Sarukhanyan, Tipack Ayothyapattanam Shanmugam & Thomas Dandekar. (2022) In Silico Studies Reveal Peramivir and Zanamivir as an Optimal Drug Treatment Even If H7N9 Avian Type Influenza Virus Acquires Further Resistance. Molecules 27:18, pages 5920.
Crossref
Crossref
Han Ju, Lingxin Hou, Fabao Zhao, Ying Zhang, Ruifang Jia, Laura Guizzo, Anna Bonomini, Jiwei Zhang, Zhen Gao, Ruipeng Liang, Chiara Bertagnin, Xiujie Kong, Xiuli Ma, Dongwei Kang, Arianna Loregian, Bing Huang, Xinyong Liu & Peng Zhan. (2022)
Iterative Optimization and Structure–Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors
via
Targeting 150-Cavity
. Journal of Medicinal Chemistry 65:17, pages 11550-11573.
Crossref
Crossref
Hao Chang, Yu Mei, Yidan Li & Luqing Shang. (2022) An AIE and ESIPT based neuraminidase fluorescent probe for influenza virus detection and imaging. Talanta 247, pages 123583.
Crossref
Crossref
Chanakan Winyakul, Weerachai Phutdhawong, Poomipat Tamdee, Jitnapa Sirirak, Thongchai Taechowisan & Waya S. Phutdhawong. (2022) 2,5-Diketopiperazine Derivatives as Potential Anti-Influenza (H5N2) Agents: Synthesis, Biological Evaluation, and Molecular Docking Study. Molecules 27:13, pages 4200.
Crossref
Crossref
Magdalena Świerczyńska, Dagmara M. Mirowska-Guzel & Edyta Pindelska. (2022) Antiviral Drugs in Influenza. International Journal of Environmental Research and Public Health 19:5, pages 3018.
Crossref
Crossref
Sphamandla E. Mtambo, Samuel C. Ugbaja & Hezekiel M. Kumalo. (2022) Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective. Molecules 27:5, pages 1645.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannOliver Planz. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
59
96
.
Hongfei Jiang, Xiaofei Qin, Qi Wang, Qi Xu, Jie Wang, Yudong Wu, Wujun Chen, Chao Wang, Tingting Zhang, Dongming Xing & Renshuai Zhang. (2021) Application of carbohydrates in approved small molecule drugs: A review. European Journal of Medicinal Chemistry 223, pages 113633.
Crossref
Crossref
Indrapal Singh Aidhen & Naveenkumar Thoti. (2021)
Natural Products & Bioactivity Inspired Synthetic Pursuits Interfacing with Carbohydrates: Ongoing Journey with
C
‐Glycosides
. The Chemical Record 21:11, pages 3131-3177.
Crossref
Crossref
Rueshandra Roosenhoff, Martin Schutten, Vaughan Reed, Barry Clinch, Anne van der Linden, Ron A.M. Fouchier & Pieter L.A. Fraaij. (2021) Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS). Antiviral Research 189, pages 105060.
Crossref
Crossref
Dharma Rao Tompa, Aruldoss Immanuel, Srimari Srikanth & Saraboji Kadhirvel. (2021) Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. International Journal of Biological Macromolecules 172, pages 524-541.
Crossref
Crossref
Sphamadla E. Mtambo, Daniel G. Amoako, Anou M. Somboro, Clement Agoni, Monsurat M. Lawal, Nelisiwe S. Gumede, Rene B. Khan & Hezekiel M. Kumalo. (2021) Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design. Molecules 26:4, pages 880.
Crossref
Crossref
Hong-Dou Chen, Xu Wang, Shu-Le Yu, Yue-Hui Ding, Meng-Lei Wang & Jin-Na Wang. (2021) Clinical Effectiveness of Intravenous Peramivir Compared With Oseltamivir in Patients With Severe Influenza A With Primary Viral Pneumonia: A Randomized Controlled Study. Open Forum Infectious Diseases 8:1.
Crossref
Crossref
Yashwant Kumar Ratre, Naveen Kumar Vishvakarma, L. V. K. S. Bhaskar & Henu Kumar Verma. (2020) Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review. Current Microbiology 77:12, pages 3809-3820.
Crossref
Crossref
Jui-Yi Chen, Shih-Kai Wei, Chih-Cheng Lai, Teng-Song Weng & Hsin-Hua Wang. (2020) A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment. Medicina 56:2, pages 63.
Crossref
Crossref
Samir Chtita, Adnane Aouidate, Assia Belhassan, Abdellah Ousaa, Abdelali Idrissi Taourati, Bouhya Elidrissi, Mounir Ghamali, Mohammed Bouachrine & Tahar Lakhlifi. (2020)
QSAR study of
N
-substituted oseltamivir derivatives as potent avian influenza virus H5N1 inhibitors using quantum chemical descriptors and statistical methods
. New Journal of Chemistry 44:5, pages 1747-1760.
Crossref
Crossref
Yaping Hu, Binfeng Chen, Zaiqiang Lei, Hongqian Zhao, Hongxi Zhu, Peng Quan & Yongshou Tian. (2019) Synthesis and Biological Evaluation of NH2-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors. Molecules 24:11, pages 2176.
Crossref
Crossref
Nelson Lee & Michael G Ison. (2019) Inhibiting Viral Polymerase and Neuraminidase in Treating Influenza. The Journal of Infectious Diseases 219:7, pages 1013-1015.
Crossref
Crossref
Sunwen Chou & Nell S. Lurain. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
953
975
.
Lesley J. Scott. (2018) Peramivir: A Review in Uncomplicated Influenza. Drugs 78:13, pages 1363-1370.
Crossref
Crossref
Ya-Jun Yang, Xi-Wang Liu, Xiao-Jun Kong, Zhe Qin, Zeng-Hua Jiao, Shi-Hong Li & Jian-Yong Li. (2018) Preparation and Evaluation of Oseltamivir Molecularly Imprinted Polymer Silica Gel as Liquid Chromatography Stationary Phase. Molecules 23:8, pages 1881.
Crossref
Crossref
Monika Fijak, Adrian Pilatz, Mark P Hedger, Nour Nicolas, Sudhanshu Bhushan, Vera Michel, Kenneth S K Tung, Hans-Christian Schuppe & Andreas Meinhardt. (2018) Infectious, inflammatory and ‘autoimmune’ male factor infertility: how do rodent models inform clinical practice?. Human Reproduction Update 24:4, pages 416-441.
Crossref
Crossref
Morgan M. Walker, Shuming Chen, Brandon Q. Mercado, K. N. Houk & Jonathan A. Ellman. (2018) Formation of Aminocyclopentadienes from Silyldihydropyridines: Ring Contractions Driven by Anion Stabilization. Angewandte Chemie International Edition 57:22, pages 6605-6609.
Crossref
Crossref
Morgan M. Walker, Shuming Chen, Brandon Q. Mercado, K. N. Houk & Jonathan A. Ellman. (2018) Formation of Aminocyclopentadienes from Silyldihydropyridines: Ring Contractions Driven by Anion Stabilization. Angewandte Chemie 130:22, pages 6715-6719.
Crossref
Crossref
Pedro Paiva, Inês P. D. Costa, Cleide E. Ferreira, Pedro Ferreira, Andreia T. Pereira, Nuno M. F. S. A. Cerqueira, Pedro A. Fernandes & Maria J. Ramos. (2018) Studies on neuraminidase inhibition. International Journal of Quantum Chemistry 118:9.
Crossref
Crossref
Ying Li, Zhiyuan Wang, Xin Li, Wei Gong, Xiangyang Xie, Yang Yang, Wu Zhong & Aiping Zheng. (2016) In Vitro Evaluation of Absorption Characteristics of Peramivir for Oral Delivery. European Journal of Drug Metabolism and Pharmacokinetics 42:5, pages 757-765.
Crossref
Crossref
Kai-Cheng Hsu, Hui-Chen Hung, Wei-Chun HuangFu, Tzu-Ying Sung, Tony Eight Lin, Ming-Yu Fang, I-Jung Chen, Nikhil Pathak, John T.-A. Hsu & Jinn-Moon Yang. (2017) Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains. Scientific Reports 7:1.
Crossref
Crossref
Rubaiyea Farrukee & Aeron C. Hurt. (2017) Antiviral Drugs for the Treatment and Prevention of Influenza. Current Treatment Options in Infectious Diseases 9:3, pages 318-332.
Crossref
Crossref
Erhard van der Vries & Michael G. Ison. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1165
1183
.
Hui-Ling Yen. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
491
501
.
Zhengtu Li, Runfeng Li, Jing Li, Hui Xie, Yanbing Hao, Qiuling Du, Tingting Chen, Yimin Li, Rongchang Chen, Zifeng Yang & Nanshan Zhong. (2016) Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment. BMC Infectious Diseases 16:1.
Crossref
Crossref
Hassan Zaraket & Reiko Saito. (2016) Japanese Surveillance Systems and Treatment for Influenza. Current Treatment Options in Infectious Diseases 8:4, pages 311-328.
Crossref
Crossref
Yejin Jang, Hye Won Lee, Jin Soo Shin, Yun Young Go, Chonsaeng Kim, Daeho Shin, Yashwardhan Malpani, Soo Bong Han, Young-Sik Jung & Meehyein Kim. (2016) Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins. Antiviral Research 134, pages 77-88.
Crossref
Crossref
N. Lee, P.K.S. Chan, W.W.S. Tam, M.C.W. Chan, G.C.Y. Lui, A.K. Kwok, F.W.S. Ko, S.S.S. Ng, I.M.H. Yung, R.Y.K. Wong & D.S.C. Hui. (2016) Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections. International Journal of Antimicrobial Agents 48:2, pages 215-219.
Crossref
Crossref
Erik De Clercq & Guangdi Li. (2016) Approved Antiviral Drugs over the Past 50 Years. Clinical Microbiology Reviews 29:3, pages 695-747.
Crossref
Crossref
Sudhir Venkatesan, Rebecca J. Cox, Jonathan S. Nguyen-Van-Tam & Puja R. Myles. 2016. SARS, MERS and other Viral Lung Infections. SARS, MERS and other Viral Lung Infections
35
64
.
Hui-Ling Yen. (2016) Current and novel antiviral strategies for influenza infection. Current Opinion in Virology 18, pages 126-134.
Crossref
Crossref
Malak M. Alame, Elie Massaad & Hassan Zaraket. (2016) Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections. Frontiers in Microbiology 7.
Crossref
Crossref
Xu Han, Yongying Shi, Longlong Si, Zibo Fan, Han Wang, Renyang Xu, Pingxuan Jiao, Kun Meng, Zhenyu Tian, Xiaoshu Zhou, Hongwei Jin, Xinyu Wu, Hong Chen, Yongmin Zhang, Lihe Zhang, Sulong Xiao & Demin Zhou. (2016) Design, synthesis and biological activity evaluation of novel conjugated sialic acid and pentacyclic triterpene derivatives as anti-influenza entry inhibitors. MedChemComm 7:10, pages 1932-1945.
Crossref
Crossref